General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Novartis Q1 results 2015
Novartis delivered solid performance and strong innovation with several major approvals and all divisions contributing to growth
Featured news:
  • 07-Apr-2015 Corporate Responsibility at Novartis – 2014 highlights Learn more »

  • 19-Mar-2015 Shedding skin and treating psoriasis, the uncovered story of a hidden condition. Learn more »

  • 11-Feb-2015 Report says new family of drugs could save billions. Learn more »

RECENT STORIES

VIDEO

   

Stock chart